Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi®)

被引:35
|
作者
Kroon, FP [1 ]
van Dissel, JT [1 ]
Ravensbergen, E [1 ]
Nibbering, PH [1 ]
van Furth, R [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis C5P, NL-2300 RC Leiden, Netherlands
关键词
HIV-infection; salmonella typhi; polysaccharide salmonella Vi-antigen;
D O I
10.1016/S0264-410X(99)00167-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections with Salmonella species, including Salmonella typhi, are more frequently observed in HIV-infected individuals than in healthy individuals. HIV-infected individuals were vaccinated with polysaccharide vaccine against Salmonella typhi (Typhim-Vi(R)) which is assumed to be a T-cell-independent antigen. We found that the antibody response in patients with < 200 x 10(6)/l CD4(+) T lymphocytes was significantly lower compared with patients with greater than or equal to 200 x 10(6)/l CD4(+) T lymphocytes and healthy controls. The antibody response after vaccination with the polysaccharide salmonella Vi-antigen was correlated with the number of CD4(+) T lymphocytes and therefore Typhim-Vi can be considered to be a T-cell-independent type 2 antigen. The results of this study indicate that after vaccination the proportion of HIV-infected individuals with protective antibody concentrations against Salmonella typhi will be lower than in healthy controls. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2941 / 2945
页数:5
相关论文
共 50 条
  • [1] Efficacy of Vi polysaccharide vaccine against Salmonella typhi
    Arya, SC
    VACCINE, 1999, 17 (9-10) : 1015 - 1015
  • [2] Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults
    Kroon, FP
    van Dissel, JT
    Ravensbergen, E
    Nibbering, PH
    van Furth, R
    VACCINE, 2000, 19 (7-8) : 886 - 894
  • [3] Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi:: reply
    Keddy, KH
    Klugman, KP
    Robbins, JB
    VACCINE, 1998, 16 (9-10) : 871 - 872
  • [4] Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
    Klugman, KP
    Koornhof, HJ
    Robbins, JB
    LeCam, NN
    VACCINE, 1996, 14 (05) : 435 - 438
  • [5] IMPAIRED RESPONSE TO RECOMBINANT HEPATITIS-B VACCINE IN ASYMPTOMATIC HIV-INFECTED INDIVIDUALS
    TAYAL, SC
    SANKAR, KN
    AIDS, 1994, 8 (04) : 558 - 559
  • [6] Salmonella Typhim VI® Vaccine (Sanofi Pasteur MSD) for the Investigation of Antibody Deficiency to Polysaccharide: Preliminary Results of UK Study
    Evans, C. S.
    Cullinane, A. C.
    Bateman, E. A. L.
    Miller, J.
    Dhalla, F.
    Arnold, D.
    Jain, R.
    Patel, S. Y.
    Misbah, S. A.
    Ferry, B. L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S398 - S398
  • [7] Salmonellacidal antibody response to Salmonella enterica serovar Typhi in enteric fever and after vaccination with Vi capsular polysaccharide
    Barai, Lovely
    Hasan, Md Rokibul
    Haq, Jalaluddin Ashraful
    Ahsan, Chowdhury Rafiqul
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 121 : 120 - 125
  • [8] Salmonella Typhi Vi polysaccharide conjugate vaccine protects infants and children against typhoid fever
    Crump, John A.
    Oo, Win Thandar
    LANCET, 2021, 398 (10301): : 643 - 644
  • [9] Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.
    Keddy, KH
    Klugman, KP
    Hansford, CF
    Blondeau, C
    le Cam, NNB
    VACCINE, 1999, 17 (02) : 110 - 113
  • [10] Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147)
    Slayter, K. L.
    Singer, J.
    Lee, T. C. K.
    Kayhty, H.
    Schlech, W. F.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (03) : 227 - 231